Advertisement

Topics

Receptor BioLogix, Inc. Company Profile

04:50 EDT 24th June 2018 | BioPortfolio

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.

Location

1140 Veterans Boulevard, Suite A
South San Francisco
California
94080
United States of America

Contact

Phone: (650) 266-4600
Fax: (650) 952-2205
Email: info@rblx.com


News Articles [472 Associated News Articles listed on BioPortfolio]

5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling

Frequency of breast cancer subtypes among African American women in the AMBER consortium

Breast cancer subtype can be classified using standard clinical markers (estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2)), supplemented with addi...

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

Symptomatic benefits have been reported for 5-HT6 receptor antagonists in Alzheimer’s disease (AD) trials. SAM-760 is a potent and selective 5-HT6 receptor antagonist that has demonstrated central 5...

Olfactory receptor as therapeutic target in bladder cancer

(Ruhr-University Bochum) Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis. Using cell culture studies, ...

Smell receptor fuels prostate cancer progression

(Duke University) Researchers have found that an olfactory receptor plays a critical role in the progression of prostate cancer. They found that activating the receptor -- called OR51E2 -- in prostate...

Tumors Shrink, or Grow, Depending on Drug Receptor–Receptor Effect

Though inhibited by a drug, a cancer-promoting cell receptor may stage a comeback, becoming part of a receptor-receptor pair that signals cancer cells to proliferate, should growth factors be present....

Glutamate-induced and NMDA receptor-mediated neurodegeneration entails P2Y1 receptor activation

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Teveten [Abbott Laboratories]

TEVETEN (eprosartan mesylate) 400mg 600mg

Blocadren(timolol maleate)tablets [Merck & Co., Inc.]

BLOCADREN(TIMOLOL MALEATE)TABLETS

Teveten hct [Abbott Laboratories]

TEVETEN HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg

Teveten hct [Physicians Total Care, Inc.]

TEVETEN HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg

Diovan [Novartis Pharmaceuticals Corporation]

Diovan

PubMed Articles [1491 Associated PubMed Articles listed on BioPortfolio]

Research progress on significance of androgen receptor and epidermal growth factor receptor expression in estrogen receptor-negative and progesterone receptor-negative breast cancer.

In Vivo Effects of μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Peptidomimetics Following Acute and Repeated Administration.

Mu opioid receptor (μ-receptor) agonists are used for pain management, but produce adverse effects including tolerance, dependence, and euphoria. The co-administration of a μ-receptor agonist with a...

Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas.

This study aimed to identify the hormonal receptor status in uterine adenosarcoma (AS) and uterine AS with sarcomatous overgrowth (AS + SO), including those with high-grade histologic features (nuclea...

Direct modification of the 5-HT3 receptor current by some anticancer drugs.

The serotonin (5-hydroxytryptamine) type 3 (5-HT3) receptor is an important target in the control of emesis, and 5-HT3 receptor antagonists are effective against the early phase chemotherapy evoked vo...

β2-adrenergic receptor autoantibodies alleviated myocardial damage induced by β1-adrenergic receptor autoantibodies.

β1-adrenergic receptor autoantibodies (β1-AAs) and β2-adrenergic receptor autoantibodies (β2-AAs) are present in patients with heart failure (HF); however, their interrelationship with cardiac str...

Clinical Trials [1834 Associated Clinical Trials listed on BioPortfolio]

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Anti-NMDA receptor encephalitis is the most common curable non-infectious autoimmune encephalitis,but because of the lack of recognition in the clinic, usually been misdiagnosed as other...

Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist

Delinieation of GIP's effects during an oral glucose tolerance test (OGTT) in humans using GIP receptor antagonisation.

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

The investigators' proposed phase 2 clinical trial will be an open-label, non-randomized study among 80 women with metastatic breast cancer. The study treatment period will be up to twelve...

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain

We would like to evaluate the changes in nerve innervation and TRPV1 receptor expression along with microscopic changes associated with heart burn and abdominal pain

Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation

The purpose of this study is to show that PET-MR imaging can be used for obtaining a pharmacodynamic profile of drugs. By using the 5-HT1B receptor as target we also aim to find effect are...

Companies [144 Associated Companies listed on BioPortfolio]

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Receptor BioLogix

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Florida Biologix

Florida Biologix® is a Phase I/II biologics contract development, manufacturing and testing organization that offers a range of biopharmaceutical services to the biotech...

Millenium Biologix Corporation

Millenium Biologix Corporation is a leading biomedical company, developing and supplying innovative products for Regenerative Medicine in the field of skeletal disease and trauma, covering clinical an...

Millenium Biologix Incorporated

Millenium Biologix Inc. is a medical biotechnology company specializing in the commercialization of innovative products based on a proprietary synthetic bone technology. These advanced BioBone product...

More Information about "Receptor BioLogix, Inc." on BioPortfolio

We have published hundreds of Receptor BioLogix, Inc. news stories on BioPortfolio along with dozens of Receptor BioLogix, Inc. Clinical Trials and PubMed Articles about Receptor BioLogix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Receptor BioLogix, Inc. Companies in our database. You can also find out about relevant Receptor BioLogix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record